Democracy Spraffa

ITEM 12 Drug related deaths in North Lanarkshire and ADP Self-Assessment

North Lanarkshire Council · 18 October 2023
Back to IJB Performance, Finance and Audit Committee — 18 October 2023 and its agenda

Text extracted from the council's PDF. Layout and reading order may differ from the original.

Original council PDF · Download plain text

Page 1

1 
REPORT 
Item No:12 
SUBJECT: North Lanarkshire ADP – Drug Related Deaths
TO: IJB Performance, Finance & Audit
Lead Officer
for Report:
Morag Dendy Head of Planning, Performance and Quality Assurance
Author(s) of
Report
John Holleran – Strategic Lead, North Lanarkshire ADP
DATE: 18th October 2023 
1. PURPOSE OF REPORT 
This paper is coming to the IJB for: 
For approval ☐  For endorsement ☐ To note ☒ 
2. ROUTES TO THE
BOARD 
This paper has been:
Prepared By: ☒ Reviewed By: ☐ Endorsed By: ☐ 
3. RECOMMENDATIONS     
3.1       The IJB PFA is asked to: 
(1) Note the content of the report;
(2) Acknowledge the content of the National Record of Scotland (NRS) Drug Related
Deaths in North Lanarkshire report, setting out the detail of the confirmed drug
related health data from 2022, published by NRS in July 2023.
(3) Recognise that there are a range of current arrangements in place to reduce
harms. 
(4) Recognise a more detailed report on the impact of commissioned services and
progress will follow in March 2024. This will include a financial overview of
spend and forecast arrangements.

Page 2

2 
4. VARIATIONS TO DIRECTIONS? 
Yes ☐ No ☐ N/A ☒ 
5. BACKGROUND/SUMMARY OF KEY ISSUES 
5.1 The National Record of Scotland (NRS) Drug Related Deaths was published in July
2023, this report highlights the information specific to North Lanarkshire. 
5.2 A summary paper is presented at Appendix 1 providing more detail to the
summarized information noted below. 
5.3 There were Sixty-five Drug Related Deaths in North Lanarkshire in 2022, down
nineteen percent (15 deaths) on 2021. This reduction is the third fall in three
successive years. (Highest number of deaths 95 in 2019) though figures remain
high. The figures represent the fifth highest number of Drug Related Deaths on
record. 
5.4 The five-year average rate for North Lanarkshire is very similar to that seen
nationally across the reporting period. 
5.5 Drug related deaths are more prevalent in males than females in North Lanarkshire
in 2022. 
5.6 Opiates/opioids were the most common group of drugs implicated in DRD in north
Lanarkshire in 2022. 
5.7 Four of the six localities in North Lanarkshire had a reduction in DRD in 2022
compared to the previous year. 
o Airdrie Locality had largest reduction in DRD in 2022 compared to the
previous year with ten less reported deaths. The only Locality with an
increase in DRD (+5) in 2022 was Motherwell Locality. 
5.8 Over seventy percent (71%) of DRD in North Lanarkshire in 2022 had two or
more substances implicated in the cause of death. 
5.9 Alcohol was implicated in almost double the proportion (20%) of DRD in
North Lanarkshire in 2022 compared to Scotland as a whole (11%). 
5.10 The NLADP support team worked closely with key partners through the five
ADP sub-groups (below) to develop key actions in keeping with national evidence-
base, regional scoping work and learning from commissioned services to target the
right responses to reduce harms. 
5.11The following ADP sub-groups oversee and support decision making on local   
investments linked to delivering the National Mission priorities. 
(1) Prevention, Early Intervention, & Education
(2) Treatment, Care & Recovery
(3) Whole Family Approach
(4) Public Health Approach to Justice

Page 3

3 
(5) Reducing Alcohol Harms Group (pan – Lanarkshire)
(6) Drug Death Prevention Group (pan – Lanarkshire) 
5.12 The work led by the NLADP will continue to engage wider stakeholders in
analysing the impact of current services, supports and models of intervention, as
well as consider the priorities and design into the future. A stakeholder conference in
November 2023 will bring together people with lived and living experience, frontline
practitioners, managers and strategic leads to reflect on local and national
performance. Outcomes from this event will be incorporated into a fuller report to
committee in March 2024.   
6. CONCLUSIONS 
6.1 Deaths from drugs in 2022 reduced, as did the numbers across Scotland. The numbers for
North Lanarkshire remain high.
6.2 Poly-substance use is an ongoing concern, including alcohol prevalence in confirmed
deaths from drugs. More work is required to understand the right approach needed for
North Lanarkshire. This will be explore thought the Drug Death Review processes in place
and the Reducing Alcohol Harms group.
6.3 NLADP now has the appropriate processes and measures in place to offer assurances that
everything possible, to reduce harms and deaths from substances, is being considered.
This is set out in the ADP Annual Survey.
6.4 NLADP increased investments across key priority areas for the past 3 years and is working
closely with key stakeholders to review data and local intelligence to target the most
appropriate interventions in areas of concern. 
7. IMPLICATIONS 
7.1 NATIONAL OUTCOMES 
Link(s) to National Health and Wellbeing Outcomes
People are able to look after and improve their own health and wellbeing and live
in good health for longer
☒
People, including those with disabilities or long-term conditions, or who are frail,
are able to live, as far as reasonable practicable, independently and at home or in
a homely setting in their community
☐
People who use Health and Social Care Services have positive experiences of
those services, and have dignity respected
☒
Health and Social Care Services are centred on helping to maintain or improve
the quality of life of people who use those services
☒
Health and Social Care Services contribute to reducing health inequalities ☒
People who use Health and Social Care Services are safe from harm ☒
People who work in Health and Social Care Services feel engaged with the work
they do and are supported to continuously improve the information, support, care
and treatment they provide
☒
Resources are used effectively and efficiently in the provision of Health and Social
Care Services 
☒

Page 4

4 
7.2 ASSOCIATED  MEASURE(S) 
 Drug Death prevention - The Pan-Lanarkshire Drug Death Prevention group (DDPG),
a function of North and South ADP’s has been in place since 2019. The work of the
group is guided by an action plan aligned to the national approach set out in Staying
Alive and the Drug Deaths Task Force Changing lives report. NHSL, Director of Public
Health will take on the Role of Chair for the DDPG strategic group from December
2023. 
 North and South ADPs share a Drug Deaths Information Officer post providing a
supporting role in gathering data any information relating to suspected drug related
deaths. This allows the wider partnership to identify trends and patterns to target the
right responses required to reduce deaths and harms from drugs. Quarterly reports are
produces and shared by the groups. 
 The drug trends monitoring group is a quarterly meeting attended by police/ADP
stakeholders and is Chaired Public Health colleagues. The purpose of this group is to
identify and share relevant information appropriately to inform and safe lives. This
group is linked to Public Health Scotland’s RADAR alerts system to ensure our local
response is well informed and efficient. 
 A seminar to examine the challenges in relation to drug-related deaths and suicides
has been scheduled for 4th October, on behalf of the Public Protection Chief Officers
Groups (PPCOGs) for North and South Lanarkshire. PPCOGs have a responsibility
to ensure suicide prevention and drug related deaths are a priority. The seminar will
ensure all are cited on the local issues and that the responses both individually and
collectively are effective. 
• Medication Assisted Treatment (MAT) standards – 1-5 implemented and
embedded by March 2024 (6-10 beyond). Work continues to fully embed all
standards by March 2025. A dedicated North working group meets monthly to guide
this work with links to a Pan-Lanarkshire oversight group. 
• Residential rehab – assessment and access is now offered to anyone who
chooses/where appropriate to access rehab, as part of their care and treatment.
NLADP published the rehab pathways online in 2023, setting out how people can
access rehab. There has been an increase in referrals and placements following
training being delivered to frontline staff in 2023. 
• Harm reduction and Assertive Outreach – A new crisis response team has been
commissioned via NLADP, in collaboration with housing and treatment service
colleagues. The new service will deliver vital support to reach people in crisis sooner
and will connect people to support following a near fatal overdose. 
A steering group has been established to lead this work to ensure we offer a
consistent approach and make the most of the increased workforce capacity to
deliver Harm Reduction measures. This includes Naloxone provision, Blood-Bourne
Virus testing and wound care.

Page 5

5 
• Whole Family Approach – integrated authorities are tasked with increasing and
widening Family Inclusive Practice (FIP) across all treatment and care settings. 
NLADP commissioned a new family support service, independent of treatment
services, to meet the needs of families. Workforce training is underway with frontline
staff to improve family involvement in treatment and care planning, where
appropriate. This is being led by Scottish Families Affected by Alcohol and Drugs
who developed the national framework. 
• Lived and Living Experience (LLE) and those in recovery are involved in design,
delivery and evaluation of services. LLE Panels are to be established with a
dedicated post within the ADP support team out to advert to lead this work. 
NLADP has a very strong focus on listening to LLE via ADP commissioned services,
there are visible and active Recovery Communities and Tier 2 treatment services
operating across all six localities in the North. 
– LLE involvement in ADP recruitment and commissioning processes
– LLE Representation embedded across all ADP sub-group structures
– NLADP is establishing lived experience panels by March 2024. 
Young people’s voices are included in the planning, delivery and evaluation of services
with NLADP commissioning services to support young people to engage in this
process. 
– Peer-awareness and education initiatives recommissioned with youth lived-
experience panels to be established. 
Healthcare Improvement Scotland have been leading a review of mental health and
substance use support (North) this includes lived and living experience. Final
recommendations and actions for consideration to be reported in October 2023. 
7.3 FINANCIAL 
NLADP has increased investment across the sector, targeting the most appropriate
and evidence-based interventions to deliver on the Nation Mission Priorities. This is
intended to reduce harms and prevent deaths with spending decisions made via the
ADP sub-groups with approval by the ADP Board and finance groups. The year-end
position for NLADP spending is set out below: 
2020/21 Year end £2,410,584
2021/22 Year end £2,290,611
2022/23 Year end £4,219,447
2023/24 Spend forecast £4,988,194 
This paper has been reviewed by Finance: 
Yes ☐ No ☐ N/A ☒

Page 6

6 
7.4 RISK ASSESSMENT/RISK MANAGEMENT 
Relevant Risk Register
Details
Current Risk Level Risk Owner 
7.5 ENGAGEMENT & PARTICPATION 
Please tick the engagement and participation objectives that link(s) with this piece of work
and provide further details regarding the engagement and participation that was undertaken.
Objectives Further Details
☒ Involve stakeholders in the development work
aimed at achieving the national
outcomes 
□ Provide stakeholders with information on how
to get involved 
□ Ensure a diverse range of engagement and
participation and opportunities are in
place to suit different needs 
☒ Measure how well we involve community
stakeholders in the planning, design
and delivery of our services 
☒ Provide regular feedback on how stakeholder
engagement and participation is
shaping and influencing service development
and delivery 
☒ Provide support to enable stakeholder
representatives to participate meaningfully and
confidently at meetings 
□ Develop participation guidelines to ensure a
common understanding and set of
expectations for both stakeholders and
partnership staff 
□ Support engagement planning and
participation in localities, taking account of
other engagement activity and local plans
across the Community Planning
Partnership 
7.6 INEQUALITIES & FAIRER SCOTLAND DUTY 
EQIA Completed & Fairer Scotland Impact Assessment Form Completed and attached to
report: 
Yes ☐ No ☐ N/A ☒ 
EQIA added to website: 
Yes /
Date
added
☐ No ☐ N/A ☒

Page 7

7 
8. BACKGROUND PAPERS 
None. 
9. APPENDICES           
Please include a glossary of terms if not already included. 
Appendix 1
National Record of Scotland (NRS) Drug Related Deaths in North Lanarkshire
report, 2023.
This report sets out a more detailed breakdown of NRS data for confirmed Drug
Related Death in North Lanarkshire for 2022. 
CHIEF ACCOUNTABLE OFFICER (or Depute) 
Members seeking further information about any aspect of this report, please contact the
following; John Holleran on 01698 753651 john.holleran@lanarkshire.scot.nhs.uk

Page 8

8 
Direction from North Lanarkshire Integration Joint Board (IJB)
1 Reference Number 
2 Report Title 
3 Date direction issued by IJB 
4 Date from which direction takes
effect 
5 Direction to: 
6 Does this direction supersede,
revise or revoke a previous
direction – if yes, include
reference number(s) 
7 Functions covered by direction 
8 Full text of direction 
9 Budget allocated by Integration
Joint Board to carry out direction 
10 Performance Management /
Governance  arrangements 
11 Date direction will be reviewed

Page 9

[Type here] [Type here] [Type here]
Appendix 1 
P a g e 
NATIONAL RECORDS OF
SCOTLAND (NRS)
REPORTED DRUG
RELATED DEATHS (DRD)
IN NORTH
LANARKSHIRE IN 2022
A NORTH LANARKSHIRE FOCUSSED
SUMMARY OF THE NRS DATA AND
PUBLICATION 
North Lanarkshire Alcohol and Drug Partnership
28 August 2023

Page 10

1 | P a g e 
Summary ...................................................................................................................................................................................... 2
Headlines ................................................................................................................................................................................. 3
Sex ............................................................................................................................................................................................. 3
Age ............................................................................................................................................................................................ 4
Deprivation ............................................................................................................................................................................. 5
Geography ................................................................................................................................................................................... 6
Substances .................................................................................................................................................................................... 7
Opiates or Opioids .......................................................................................................................................................................... 8
Benzodiazepines ...................................................................................................................................................................... 9
Other substances ................................................................................................................................................................... 10
Annotation ..................................................................................................................................................................................... 11
CONTENTS

Page 11

2 | P a g e 
THERE WERE SIXTY FIVE DRUG RELATED DEATHS IN NORTH
LANARKSHIRE IN 2022.
This is fifteen less than 2021 and the third successive year showing a
reduction. Deaths are still high however with almost thirty more deaths in
North Lanarkshire in 2022 compared to ten years ago. 
DRUG RELATED DEATHS ARE MORE PREVELENT IN MALES THAN FEMALES
IN NORTH LANARKSHIRE IN 2022.
In North Lanarkshire in 2022 there were one and a half times more DRD
reported for males than females. Whilst this is a considerable difference and
both male and female DRD have shown a decrease from 2021 the
proportional fall is much more marked in males. Ten years ago, in 2012, there
were over four and a half more DRD reported for males in North Lanarkshire
than females. 
OPIATES/ OPIODS ARE THE MOST COMMON GROUP OF DRUGS
IMPLICATED IN DRD IN NORTH LANARKSHIRE IN 2022.
Whilst Opiates/Opioids are the most common drug implicated in DRD in North
Lanarkshire, in 2022, the proportion is considerably less than that reported
nationally (82% Scotland, 74% North Lanarkshire). The most commonly
implicated Opiate/Opioid for DRD in 2022 in North Lanarkshire differs from
what is seen nationally with Heroin/ Morphine being the most commonly
implicated in North Lanarkshire and Methadone the most commonly implicated
nationally.
SUMMARY

Page 12

3 | P a g e 
Drug Related Deaths in North Lanarkshire remain high but have fallen in
three successive years. 
• Sixty five Drug Related
Deaths in North
Lanarkshire in 2022.
• Down nineteen percent
(15 deaths) on 2021.
• Third fall in three
successive years. (Highest
number of deaths 95 in
2019).
• Fifth highest number of
Drug Related Deaths on
record.
• Five year average rate
very similar to that seen
nationally across the
reporting period.
HEADLINES

Page 13

3 | P a g e 
Reduction in deaths over six times greater in males than females. 
 There were one and a half times the number of drug related deaths for males
(39, 60%) compared to females (26, 40%) in 2022.
 The gap has narrowed, for the second consecutive year, with one point nine
times the number of drug related deaths for males (52, 65%) compared to
females (28, 35%) in 2021.
 Reduction in deaths over six times greater in males (13 less deaths) than females
(2 less deaths). 
SEX

Page 14

4 | P a g e 
Thirty eight percent of DRD in 2022 in North Lanarkshire occurred within
the thirty five to forty four age group. 
 The age profile in North
Lanarkshire is broadly
similar to the national
profile for 2018-2022
averages per 100,000
population deaths.
 Deaths per 100,000
population in the 25-34
age group in North
Lanarkshire is
considerably higher than
what is seen nationally for
2018-2022 averages (41.3
North Lanarkshire,
27.9 Scotland).
 In 2022 the age group
with the largest
proportion of deaths was
the 35-44 age group
(38%) followed by the
45-54 (32%) age group.
This differs from 2021
where the this was
reversed i.e. most deaths
in 45-54 age group
followed by 35-44 age
group.
AGE

Page 15

5 | P a g e 
More than half (58%) of the DRD reported in 2022 in North Lanarkshire
were for individuals living in the most deprived area (Scottish Index of
Multiple Deprivation (SIMD) quintile 1). 
 Almost ninety percent
(86%) of DRD in North
Lanarkshire in 2022 were
for individuals in the two
most deprived areas
(SIMD 1 and 2).
 In North Lanarkshire in
2022 there were ten
percent more (86%) DRD
in the two most deprived
areas compared to
Scotland as a whole
(76%).
 Less than four percent of
DRD in North Lanarkshire
in 2022 were for
individuals in the two
least deprived areas
(SIMD 4 and 5).
DEPRIVATION

Page 16

6 | P a g e 
All localities in North Lanarkshire had five or more DRD in 2022. 
 Four of the six localities in North Lanarkshire had a reduction in DRD in 2022
compared to the previous year.
 Airdrie Locality had largest reduction in DRD in 2022 compared to the previous
year with ten less reported deaths.
 The only Locality with an increase in DRD (+5) in 2022 was Motherwell Locality.
GEOGRAPHY

Page 17

7 | P a g e 
Opiates/Opioids are the most common drug implicated in DRD in 2022 in
North Lanarkshire. 
 Whilst Opiates/Opioids are the most common drug implicated in DRD in North
Lanarkshire in 2022 the proportion is considerably less than that reported
nationally (82% Scotland, 74% North Lanarkshire).
 A similar relationship can be seen for benzodiazepines and Gabapentin and/or
Pregabalin (Benzodiazepines 57% Scotland, 49% North Lanarkshire, Gabapentin
and/or Pregabalin 35% Scotland, 28% North Lanarkshire).
 Alcohol was implicated in a considerably larger proportion of DRD in 2022 in
North Lanarkshire compared to Scotland (20% North Lanarkshire, 11%
Scotland).
 Over seventy percent (71%) of DRD in North Lanarkshire in 2022 had two or
more substances implicated in the cause of death.
SUBSTANCES

Page 18

8 | P a g e 
Methadone was implicated in almost half the proportion of DRD in North
Lanarkshire (23%) compared to Scotland (45%) in 2022. 
 Buprenorphine was implicated in more than double the proportion of DRD in
North Lanarkshire (14%) compared to Scotland (6%) in 2022. Every DRD in
North Lanarkshire in 2022 where Buprenorphine has been implicated was a poly
drug death; on average there were 4 drugs implicated in every DRD where
Buprenorphine was implicated.
 In North Lanarkshire in 2022 the most commonly implicated Opiate/ Opioid for
DRD was Heroin/ Morphine (40%). This differs from Scotland were Methadone
was the most commonly implicated Opiate/ Opioid (45%); Methadone was
implicated in twenty-three percent of DRD in North Lanarkshire.
OPIATES OR OPIOIDS

Page 19

9 | P a g e 
With the exception of Etizolam all categories of Benzodiazepines are
implicated in a smaller proportion of DRD in North Lanarkshire in 2022
than across Scotland. 
 Any "Prescribable" benzodiazepine were implicated in half (9%) the proportion of
DRD in North Lanarkshire in 2022 compared to Scotland as a whole (18%).
 Diazepam was implicated in five times the proportion (15%) of DRD in 2022
across Scotland compared to North Lanarkshire (3%).
BENZODIAZEPINES

Page 20

10 | P a g e 
Alcohol was implicated in almost double the proportion (20%) of DRD in
North Lanarkshire in 2022 compared to Scotland as a whole (11%). 
 Cocaine was implicated in more than one in three (35%) of DRD in North
Lanarkshire in 2022, which is identical to the proportion across Scotland.
 In 2021 Cocaine was implicated in twenty-seven percent of DRD in North
Lanarkshire. Although this (35% reported in 2022) is a proportional increase of
seven percent it equates to just one more DRD were Cocaine was implicated in
2022 (23 deaths) compared to 2021 (22 deaths).
 Gabapentin and/or Pregabalin was less commonly implicated (7% less) for DRD
in 2022 in North Lanarkshire (28%) compared to Scotland as a whole (35%).
OTHER SUBSTANCES

Page 21

11 | P a g e 
Pages 3 and 4 
1) Populations for 2022 are not available at the time of publication so 2021
populations are used to calculate rates for 2022.
Page 4
2) Some age groups have been aggregated to protect anonymity.
Pages 7,8, 9 and 10
1) More than one drug may be reported per death. These are mentions of each
drug, and will not add up to give total deaths.
ANNOTATION

Page 22

12